<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK258641" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK258641/" /><meta name="ncbi_pagename" content="Susceptibility to Infection-Induced Acute Encephalopathy 3 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Susceptibility to Infection-Induced Acute Encephalopathy 3 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Susceptibility to Infection-Induced Acute Encephalopathy 3" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/12/04" /><meta name="citation_author" content="Derek Neilson" /><meta name="citation_pmid" content="25473726" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK258641/" /><meta name="citation_keywords" content="Acute Necrotizing Encephalopathy (ANE1)" /><meta name="citation_keywords" content="Acute Necrotizing Encephalopathy (ANE1)" /><meta name="citation_keywords" content="E3 SUMO-protein ligase RanBP2" /><meta name="citation_keywords" content="RANBP2" /><meta name="citation_keywords" content="Susceptibility to Infection-Induced Acute Encephalopathy 3" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Susceptibility to Infection-Induced Acute Encephalopathy 3" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Derek Neilson" /><meta name="DC.Date" content="2014/12/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK258641/" /><meta name="description" content="Infection-induced acute encephalopathy 3 (IIAE3) is the susceptibility to recurrent acute necrotizing encephalopathy (ANE) caused by a heterozygous pathogenic variant in RANBP2. ANE refers to the specific neurologic presentation in which bilateral symmetric thalamic, midbrain, and/or hindbrain lesions occur within days following the onset of an acute viral illness caused by influenza A, influenza B, parainfluenza II, human herpes virus 6, coxsackie virus, or an enterovirus. Although most IIAE3 occurs before age six years, first episodes have been observed in teenagers and adults. ANE begins within 12 hours to three or four days of the first awareness of viral symptoms (fever, cough, rhinorrhea, vomiting, diarrhea, and malaise). The most common sign of ANE is lethargy that progresses to coma (which may last for weeks) and seizures (in 50%). One third of affected individuals die during the acute phase of the encephalopathy; of the survivors, one half have permanent neurologic damage and the remainder have no discernible residual symptoms. Fifty per cent of persons with IIAE3 will have at least one repeat episode and some will have multiple repeat episodes" /><meta name="og:title" content="Susceptibility to Infection-Induced Acute Encephalopathy 3" /><meta name="og:type" content="book" /><meta name="og:description" content="Infection-induced acute encephalopathy 3 (IIAE3) is the susceptibility to recurrent acute necrotizing encephalopathy (ANE) caused by a heterozygous pathogenic variant in RANBP2. ANE refers to the specific neurologic presentation in which bilateral symmetric thalamic, midbrain, and/or hindbrain lesions occur within days following the onset of an acute viral illness caused by influenza A, influenza B, parainfluenza II, human herpes virus 6, coxsackie virus, or an enterovirus. Although most IIAE3 occurs before age six years, first episodes have been observed in teenagers and adults. ANE begins within 12 hours to three or four days of the first awareness of viral symptoms (fever, cough, rhinorrhea, vomiting, diarrhea, and malaise). The most common sign of ANE is lethargy that progresses to coma (which may last for weeks) and seizures (in 50%). One third of affected individuals die during the acute phase of the encephalopathy; of the survivors, one half have permanent neurologic damage and the remainder have no discernible residual symptoms. Fifty per cent of persons with IIAE3 will have at least one repeat episode and some will have multiple repeat episodes" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK258641/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/iiae3/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK258641/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D6293E0414061000000000ACB0409.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK258641_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK258641_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ssadh/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cdsp/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK258641_"><span class="title" itemprop="name">Susceptibility to Infection-Induced Acute Encephalopathy 3</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Acute Necrotizing Encephalopathy (ANE1)</div><p class="contrib-group"><span itemprop="author">Derek Neilson</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK258641_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK258641_ai__"><div class="contrib half_rhythm"><span itemprop="author">Derek Neilson</span>, MD<div class="affiliation small">Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@noslien.kered" class="oemail">gro.cmhcc@noslien.kered</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 4, 2014</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="iiae3.Summary" itemprop="description"><h2 id="_iiae3_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Infection-induced acute encephalopathy 3 (IIAE3) is the susceptibility to recurrent acute necrotizing encephalopathy (ANE) caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RANBP2.</i> ANE refers to the specific neurologic presentation in which bilateral symmetric thalamic, midbrain, and/or hindbrain lesions occur within days following the onset of an acute viral illness caused by influenza A, influenza B, parainfluenza II, human herpes virus 6, coxsackie virus, or an enterovirus. Although most IIAE3 occurs before age six years, first episodes have been observed in teenagers and adults. ANE begins within 12 hours to three or four days of the first awareness of viral symptoms (fever, cough, rhinorrhea, vomiting, diarrhea, and malaise). The most common sign of ANE is lethargy that progresses to coma (which may last for weeks) and seizures (in 50%). One third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals die during the acute phase of the encephalopathy; of the survivors, one half have permanent neurologic damage and the remainder have no discernible residual symptoms. Fifty per cent of persons with IIAE3 will have at least one repeat episode and some will have multiple repeat episodes</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>IIAE3 is suspected in individuals with typical clinical and MRI findings, and is confirmed in those with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RANBP2.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatments for IIAE3 remain anecdotal and it should be noted that patients have recovered without specific intervention. Treatment is aimed at reducing the inflammatory state by administration of corticosteroids during an acute episode of encephalopathy (not supported by data from IIAE-3-specific studies) as well as IVIg, plasmapheresis, and TNF&#x003b1; antagonists with varied, but overall limited, therapeutic effects.</p><p><i>Prevention of primary manifestations:</i> Routine vaccinations and yearly influenza vaccinations are recommended, although there are theoretic concerns for live influenza and cellular pertussis preparations. No studies have suggested that vaccinations cause acute necrotizing encephalopathy (ANE) in an individual <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><i>Surveillance:</i> No standard tests allow prediction of the triggering of an ANE event or progression of an event once one occurs.</p><p><i>Agents/circumstances to avoid:</i> Avoid individuals who are ill with an infectious disease and adhere to strict precautions regarding hand washing. Based on a single case report of ANE in one individual (not known to have a <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>), avoidance of cellular pertussis in DTaP immunization is recommended.</p><p><i>Evaluation of relatives at risk:</i> In a family with IIAE3, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of at-risk first-degree relatives, especially children, is warranted so that those who have inherited the <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can benefit from prompt intervention in the early stages of ANE.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Susceptibility to IIAE3 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. To date the majority of individuals diagnosed with IIAE3 have a parent who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however, due to reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, the parent may not have manifested the disease state. Also, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with susceptibility to IIAE3 may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant. Each child of an individual with susceptibility to IIAE3 has a 50% chance of inheriting the pathogenic variant. When the <i>RANBP2</i> pathogenic variant has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for pregnancies at increased risk is possible.</p></div></div><div id="iiae3.Diagnosis"><h2 id="_iiae3_Diagnosis_">Diagnosis</h2><p>Infection-induced acute encephalopathy 3 (IIAE3) refers to the susceptibility to recurrent acute necrotizing encephalopathy (ANE) caused by mutation of <i>RANBP2</i> that is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Acute necrotizing encephalopathy refers to the specific neurologic presentation in which bilateral symmetric thalamic, midbrain, and/or hindbrain lesions occur within days following the onset of an acute viral illness [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1995.555">Mizuguchi et al 1995</a>].</p><div id="iiae3.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Infection-induced acute encephalopathy 3 (IIAE3) <b>is suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>No preceding developmental or neurologic defects [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1995.555">Mizuguchi et al 1995</a>, <a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>]</div></li><li class="half_rhythm"><div>Signs at onset that can be attributed to a viral trigger, such as fever, cough, rhinorrhea, vomiting, diarrhea, and malaise</div><ul><li class="half_rhythm"><div>Viruses known to precipitate ANE include influenza A, influenza B, parainfluenza II, human herpesvirus 6, coxsackie virus, and enteroviruses [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>].</div></li><li class="half_rhythm"><div>The only bacterium known to precipitate ANE is <i>Mycoplasma pneumonia</i> [<a class="bk_pop" href="#iiae3.REF.ashtekar.2003.634">Ashtekar et al 2003</a>].</div></li></ul></li><li class="half_rhythm"><div>Onset of ANE beginning within 12 hours to three or four days of the first awareness of viral symptoms. The most common sign of ANE is lethargy that progresses to coma and seizures (50%).</div></li><li class="half_rhythm"><div>At the time of hospital admission, brain MRI demonstrating:</div><ul><li class="half_rhythm"><div class="half_rhythm">T<sub>2</sub>- and FLAIR-weighted hyperintensities in the bilateral thalami, midbrain, cerebellum, pons, and brain stem [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1995.555">Mizuguchi et al 1995</a>, <a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>];</div></li><li class="half_rhythm"><div class="half_rhythm">Additional involved regions including the limbic system (e.g., the amygdala, mammillary bodies) and lateral regions such as the claustra and external capsules [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>];</div><div class="half_rhythm">Note: The presence of lesions in these areas should prompt consideration of IIAE3, even in the absence of recurrence or family history [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Less commonly, involvement of the basal ganglia [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>].</div><div class="half_rhythm">Note: It has been reported that gadolinium can identify lesions prior to their recognition on noncontrast MRI [<a class="bk_pop" href="#iiae3.REF.yoshida.2013.921">Yoshida et al 2013</a>].</div></li></ul></li><li class="half_rhythm"><div>Pathologic findings that are similar to those of Leigh syndrome and Wernicke encephalopathy (i.e., regions of neuronal necrosis, capillary proliferation and dilation, hemorrhage, and edema, without local infiltration of other inflammatory cells) [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>]. The axis for these lesions would suggest a vascular distribution coming from the posterior circulation [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>]. The distribution of lesions matches the MRI findings.</div></li></ul></div><div id="iiae3.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of IIAE3 is based on the presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RANBP2</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a class="figpopup" href="/books/NBK258641/table/iiae3.T.summary_of_molecular_genetic_tes/?report=objectonly" target="object" rid-figpopup="figiiae3Tsummaryofmoleculargenetictes" rid-ob="figobiiae3Tsummaryofmoleculargenetictes">Table 1</a>). Only three single-nucleotide variants &#x02013; clustered in the "leucine-rich" <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (exons 12 and 14) &#x02013; have been identified to date (see <a href="#iiae3.Molecular_Genetics">Molecular Genetics</a>) [<a class="bk_pop" href="#iiae3.REF.neilson.2009.44">Neilson et al 2009</a>].</p><div id="iiae3.T.summary_of_molecular_genetic_tes" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Susceptibility to Infection-Induced Acute Encephalopathy 3</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK258641/table/iiae3.T.summary_of_molecular_genetic_tes/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iiae3.T.summary_of_molecular_genetic_tes_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_iiae3.T.summary_of_molecular_genetic_tes_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_iiae3.T.summary_of_molecular_genetic_tes_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_iiae3.T.summary_of_molecular_genetic_tes_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_iiae3.T.summary_of_molecular_genetic_tes_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RANBP2</i></td><td headers="hd_h_iiae3.T.summary_of_molecular_genetic_tes_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_iiae3.T.summary_of_molecular_genetic_tes_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27/86 (31%)&#x000a0;<sup>3</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="iiae3.TF.1.1"><p class="no_margin">See <a href="/books/NBK258641/#iiae3.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#iiae3.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="iiae3.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="iiae3.TF.1.3"><p class="no_margin">Author [unpublished data]. Denominator represents unrelated probands who either have a positive family history or represent <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family). Each <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> independently fulfilled criteria for ANE.</p></div></dd></dl></div></div></div></div></div><div id="iiae3.Clinical_Characteristics"><h2 id="_iiae3_Clinical_Characteristics_">Clinical Characteristics</h2><div id="iiae3.Clinical_Description"><h3>Clinical Description</h3><p>Most infection-induced acute encephalopathy 3 (IIAE3) (which by definition is caused by mutation of <i>RANBP2</i>) occurs before age six years, with the majority of cases occurring between age nine months and two years [<a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>]. Although the number of first episodes decreases with age, first episodes of IIAE3 have been observed in teenagers and adults [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>].</p><p>Acute necrotizing encephalopathy (ANE) is always preceded by a febrile infection that is usually viral [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1995.555">Mizuguchi et al 1995</a>]. Viruses known to precipitate ANE include influenza A, influenza B, parainfluenza II, human herpesvirus 6, coxsackie virus, and enteroviruses [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>]. <i>Mycoplasma pneumoniae</i> has also been implicated [<a class="bk_pop" href="#iiae3.REF.ashtekar.2003.634">Ashtekar et al 2003</a>]. Initial symptoms are attributable to the virus and may include fever, vomiting, diarrhea, cough, rhinorrhea, or rash.</p><p>The progression to acute neurologic dysfunction may occur within hours to days following the onset of the febrile infection. Initial manifestations include decreased consciousness and seizures. Neurologic findings that may accompany the encephalopathy include hallucination, ataxia, hypotonia, hypertonia, and decerebrate or decorticate posturing.</p><p>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons present with or progress to coma [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1995.555">Mizuguchi et al 1995</a>, <a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>]. The comatose state, which may last from days to months, is usually on the order of weeks.</p><p>One third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals die during the acute phase of the encephalopathy [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1997.81">Mizuguchi 1997</a>, <a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>]. Initially, all survivors of ANE will demonstrate losses of multiple developmental skills such as walking, speaking, and self-care. These may be regained over a period of weeks to months [<a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>]. Of the survivors, one half are left with permanent neurologic damage and the remainder have no discernible residual symptoms or intellectual disability [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1997.81">Mizuguchi 1997</a>, <a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>].</p><p>Fifty per cent of persons with IIAE3 will have at least one repeat episode and some will have multiple repeat episodes [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>]. Whereas additional episodes are most likely to take place in childhood, recurrence in teenagers and adults has been reported. Repeat episodes presumably result in additional cellular damage and, thus, outcomes are progressively worse, regardless of the degree of initial clinical recovery [<a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>].</p><p><b>Laboratory findings.</b> In the acute phase in persons with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> ANE, IL6 and TNF&#x003b1; have been inconsistently elevated in the serum and CSF [<a class="bk_pop" href="#iiae3.REF.kansagra.2011.400">Kansagra &#x00026; Gallentine 2011</a>] (see <a href="#iiae3.Differential_Diagnosis">Differential Diagnosis</a>). These analytes have not been systematically evaluated in IIAE3.</p></div><div id="iiae3.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The three single nucleotide variants identified in <i>RANBP2</i> (see <a href="#iiae3.Molecular_Genetics">Molecular Genetics</a>) result in the same <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#iiae3.REF.neilson.2009.44">Neilson et al 2009</a>].</p></div><div id="iiae3.Penetrance"><h3>Penetrance</h3><p>Penetrance is incomplete and age dependent. Forty percent of heterozygotes for a <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will manifest an episode of acute necrotizing encephalopathy (ANE); 50% of such episodes occur before age two years. A first episode becomes less likely with age, but can occur in adulthood [<a class="bk_pop" href="#iiae3.REF.neilson.2009.44">Neilson et al 2009</a>].</p></div><div id="iiae3.Anticipation"><h3>Anticipation</h3><p>Genetic <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> does not occur with IIAE3, although families may appear to have anticipation on the basis of earlier recognition of the diagnosis in subsequent generations [<a class="bk_pop" href="#iiae3.REF.neilson.2009.44">Neilson et al 2009</a>].</p></div><div id="iiae3.Nomenclature"><h3>Nomenclature</h3><p>The term "acute necrotizing encephalopathy" (ANE) continues to be used for ANE that is <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> (i.e., a single occurrence in a family of unknown cause).</p><p>Infection-induced acute encephalopathy 3 (IIAE3) is reserved for ANE with a documented <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>The infection-induced acute encephalopathy (IIAE) series describes genetic predispositions to CNS dysfunction following infections:</p><ul><li class="half_rhythm"><div>IIAE1, IIAE2, IIAE5, and IIAE6 refer to genetic variants that allow herpes simplex virus to invade the CNS.</div></li><li class="half_rhythm"><div>IIAE3 refers to non-neuronopathic infections of different types that can trigger encephalopathy without evidence of direct CNS invasion.</div></li><li class="half_rhythm"><div>IIAE4 refers specifically to influenza-mediated encephalopathy, also without CNS invasion factor [<a class="bk_pop" href="#iiae3.REF.shinohara.2011.512">Shinohara et al 2011</a>].</div></li></ul><p>ANE1 defines the previous symbol assigned to the 2q12.1-2q13 <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> in which <i>RANBP2</i> pathogenic variants were eventually identified. (The ANE numbering system [i.e., ANE2, ANE3, and so on] was started in recognition that other kindreds with ANE do not show linkage to the same region [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>] ; however, to date, no families have been large enough to allow genetic studies to associate <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> loci or genes with these additional loci.)</p><p>Note: While ANE caused by mutation of <i>RANBP2</i> has been termed ANE1 in some publications, it has been termed IIAE3 in OMIM.</p></div><div id="iiae3.Prevalence"><h3>Prevalence</h3><p>Acute necrotizing encephalopathy (ANE) is underreported; the prevalence and incidence of ANE remain unknown. Due to ascertainment bias, it is not possible to estimate the proportion of ANE that results from mutation of <i>RANBP2</i> (and thus is classified as infection-induced acute encephalopathy 3 [IIAE3]).</p><ul><li class="half_rhythm"><div>In a two-year surveillance study of influenza in the UK, four cases of ANE were identified, suggesting an incidence in the total population of approximately one per 30 million person-years [<a class="bk_pop" href="#iiae3.REF.goenka.2014.775">Goenka et al 2014</a>]. However, this would be an underestimate as influenza is not the only cause of ANE.</div></li><li class="half_rhythm"><div>An estimate of ten to 50 cases of ANE in the United States per year seems appropriate [Author, personal prediction based on observed cases] and may depend on the viral strains present in a given year.</div></li></ul></div></div><div id="iiae3.Genetically_Related_Allelic_Disord"><h2 id="_iiae3_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> mutation of <i>RANBP2.</i></p><p>Sporadic cancers (including myelomonocytic leukemia and inflammatory myofibroblastic tumor) occurring as single tumors in the absence of any other findings of this syndrome may harbor somatic pathogenic variants in <i>RANBP2</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable. For more details see Molecular Genetics, <a href="#iiae3.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</a>.</p></div><div id="iiae3.Differential_Diagnosis"><h2 id="_iiae3_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Other causes of acute necrotizing encephalopathy (ANE).</b> ANE occurs in both <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> forms. In a child with a first onset, certain brain MRI findings, such as the presence of lesions in the limbic system or external capsule, may provide clues to identify IIAE3, but otherwise the familial and sporadic forms are indistinguishable [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>]. While multiple different viruses can trigger ANE, no other genetic predispositions for ANE have been identified.</p><p><b>Evidence for <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity.</b> Locus heterogeneity is suggested by families in which multiple members have ANE, but do not have pathogenic variants in <i>RANBP2</i> and whose <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> fails to show linkage to the <i>RANBP2</i> region [<a class="bk_pop" href="#iiae3.REF.neilson.2009.44">Neilson et al 2009</a>, <a class="bk_pop" href="#iiae3.REF.marco.2010.e693">Marco et al 2010</a>]. For these additional families, the rarity of the condition favors a genetic predisposition rather than chance co-occurrence.</p><p><b>IIAE4, influenza-associated encephalopathy</b> (OMIM <a href="http://www.omim.org/entry/614212" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614212</a>). The initial presentation is very similar to IIAE3, with acute neurologic decompensation following an influenza infection; however, brain MRI demonstrates either no abnormalities or diffuse swelling. Thermolabile alleles of carnitine palmitoyl transferase II (CPT) that are prevalent in Japan and inactivate CPTII during periods of fever have been implicated as a susceptibility factor [<a class="bk_pop" href="#iiae3.REF.shinohara.2011.512">Shinohara et al 2011</a>].</p><p><b>Other disorders that can present with findings similar to those of IIAE3</b></p><ul><li class="half_rhythm"><div><b>Acute bilateral striatal necrosis</b> can be precipitated commonly by <i>Mycoplasma pneumoniae</i> [<a class="bk_pop" href="#iiae3.REF.larsen.1996.1124">Larsen &#x00026; Crisp 1996</a>]. It presents as a febrile encephalopathy with symmetric lesions detected on brain MRI primarily in the putamen and globus pallidum. No contributing <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> has been identified.</div></li><li class="half_rhythm"><div><b>Alpers-Huttenlocher syndrome (AHS)</b> (see <a href="/books/n/gene/alpers/"><i>POLG</i>-Related Disorders</a>). One of the most severe phenotypic manifestations in the spectrum of <i>POLG</i>-related disorders, AHS is characterized by a progressive and ultimately severe encephalopathy with intractable epilepsy and hepatic failure. The age of onset, the rate of neurologic degeneration, the presence of hepatic failure, and the age of death vary. The brain MRI lesions of AHS are similar to those of ANE. Typically a childhood-onset disorder, AHS does not require a preceding inflammatory event. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>. Biallelic pathogenic variants in <i>POLG</i> are causative.</div></li><li class="half_rhythm"><div><b>Leigh syndrome (LS) and other mitochondrial disorders</b> (see <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>). LS manifests as a progressive neurodegenerative disorder resulting from a variety of defects in mitochondrial function. Blood lactate is typically elevated, but can be variable. LS can become acutely worse during febrile infections, possibly producing a presentation similar to ANE. While the basal ganglia are most characteristically <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, other brain regions such as the thalami can be symmetrically affected as well [<a class="bk_pop" href="#iiae3.REF.baertling.2014.257">Baertling et al 2014</a>]. The histopathologic characteristics of ANE overlap with those of LS [<a class="bk_pop" href="#iiae3.REF.mizuguchi.1995.555">Mizuguchi et al 1995</a>].</div></li><li class="half_rhythm"><div><b>Acute disseminated encephalomyelitis (ADEM)</b> is a demyelinating disorder that is considered to be autoimmune in nature. It affects the CNS white matter, but can involve gray matter as well, presenting with an encephalopathy. The triggers for this disorder, which include vaccinations and infections, precede the encephalopathy by weeks rather than days. Although predominance of white matter lesions and asymmetric involvement support the diagnosis of ADEM rather than ANE, involvement of the thalami can make it difficult to distinguish the two [<a class="bk_pop" href="#iiae3.REF.alper.2012.1408">Alper 2012</a>]. (See also <a href="/books/n/gene/leukodys-ov/">Leukodystrophy Overview</a>.)</div></li><li class="half_rhythm"><div><b>Multiple sclerosis (MS)</b> is not a true consideration in the differential diagnosis; however, in the past &#x02013; for lack of a better diagnosis &#x02013; some adults with ANE were diagnosed with "atypical MS." When MS or similar terminology is used to describe a finding in a family member, further investigation and review of medical records are warranted to ensure its accuracy. An experienced neurologist will be able to differentiate the brain MRI lesions of ANE from the lesions found in MS, which tend to be multifocal white matter lesions [<a class="bk_pop" href="#iiae3.REF.karussis.2014.134">Karussis 2014</a>].</div></li></ul></div><div id="iiae3.Management"><h2 id="_iiae3_Management_">Management</h2><div id="iiae3.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with susceptibility to infection-induced acute encephalopathy 3 (IIAE3), the following evaluations are recommended after an episode of acute necrotizing encephalopathy (ANE):</p><ul><li class="half_rhythm"><div>Brain MRI during a quiescent period. This should demonstrate resolution of the edema signals and may reveal regions of necrosis. This interval baseline will be helpful in distinguishing new versus old lesions in subsequent febrile events.</div></li><li class="half_rhythm"><div>Rehabilitation/OT/PT consultation</div></li><li class="half_rhythm"><div>Neurology consultation</div></li><li class="half_rhythm"><div>Clinical genetics consultation</div></li></ul></div><div id="iiae3.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Treatment has been aimed at reducing the inflammatory state [<a class="bk_pop" href="#iiae3.REF.okumura.2009.221">Okumura et al 2009</a>, <a class="bk_pop" href="#iiae3.REF.bergamino.2012.384">Bergamino et al 2012</a>].</p><p>During an acute episode of encephalopathy, early administration of corticosteroids has been associated with improved outcomes in patients with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> ANE [<a class="bk_pop" href="#iiae3.REF.okumura.2009.221">Okumura et al 2009</a>]. Although this treatment course is also advocated for IIAE3, no specific studies have been performed to support that.</p><p>Anecdotally, treatment has mirrored that of acute demyelinating encephalomyelopathy (ADEM) with the use of steroids, IVIg, and plasmapheresis. TNF&#x003b1; antagonists have also been used. Because the diagnosis of ANE is usually made days into the encephalopathy, initiation of therapy occurs after the onset of damage. Thus, anecdotally, these interventions have shown varied, but overall limited, therapeutic effects.</p><p>Repeat episodes of encephalopathy presumably result in cellular damage and, thus, outcomes become progressively worse [<a class="bk_pop" href="#iiae3.REF.neilson.2003.226">Neilson et al 2003</a>], prompting the need for close attention to new febrile events and early intervention as follows:</p><ul><li class="half_rhythm"><div>Prior identification of an <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual allows early recognition of an ANE episode and prompt steroid therapy, which may result in a reduction in disease severity.</div></li><li class="half_rhythm"><div>With behavioral changes during febrile episodes, early evaluation by a neurologist with prompt hospitalization, CNS imaging, and initiation of steroid therapy may provide the best chance to terminate an ANE episode before damage occurs.</div></li></ul></div><div id="iiae3.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>Routine vaccinations and yearly influenza vaccinations are recommended, but caution with certain live virus vaccines may need to be observed (see <a href="#iiae3.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</a>). No evidence exists to suggest that vaccinations cause acute necrotizing encephalopathy (ANE) in an individual <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="iiae3.Surveillance"><h3>Surveillance</h3><p>No standard tests allow prediction of the triggering of an ANE event or progression of an event once one occurs.</p><p>In intervals between ANE events neurologic function is stable. Follow-up evaluations focus on developmental progression and addressing functional deficits related to neurologic damage. In the absence of other risks for seizures, anticonvulsant therapy started during an ANE event can often be discontinued.</p></div><div id="iiae3.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid individuals who are ill with an infectious disease and adhere to strict precautions regarding hand washing.</p><p>Only one episode of ANE following an immunization has been reported: cellular pertussis was given to a child age six months representing a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) in whom <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> was not performed [<a class="bk_pop" href="#iiae3.REF.aydin.2010.1281">Aydin et al 2010</a>]. Because the likely causative component was the cellular pertussis, the acellular DTaP is preferred.</p><p>In mice, intranasal inoculation of certain influenza subtypes can result in CNS invasion [<a class="bk_pop" href="#iiae3.REF.shinya.2000.187">Shinya et al 2000</a>]. Although this is unlikely with the live attenuated influenza virus, it may be preferable to choose an injectable form instead.</p></div><div id="iiae3.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>In a family with IIAE3 in which the disease-associated <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of at-risk first-degree relatives, especially children, is warranted so that those who have inherited the <i>RANBP2</i> pathogenic variant can benefit from prompt intervention in the early stages of ANE (see <a href="#iiae3.Treatment_of_Manifestations">Treatment of Manifestations</a>).</p><p>The ability to clarify the genetic status of at-risk relatives also reduces unnecessary utilization of resources, such as emergency room visits, for those who have not inherited the <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p>See <a href="#iiae3.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="iiae3.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="iiae3.Genetic_Counseling"><h2 id="_iiae3_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="iiae3.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Susceptibility to infection-induced acute encephalopathy 3 (IIAE3) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="iiae3.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Many individuals diagnosed with susceptibility to IIAE3 have a parent who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; however, due to incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, the parent may not have manifested the disease state.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with susceptibility to IIAE3 may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Although the proportion of cases caused by <i>de novo</i> pathogenic variants is unknown, to date the majority of molecularly confirmed cases have resulted from inherited pathogenic variants.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include testing for the pathogenic variant identified in the proband. Evaluation of parents may determine that one parent has the pathogenic variant but has escaped previous ascertainment because of a milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, an alternate diagnosis, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or late occurrence of a first episode. Therefore, an apparently negative family history cannot be confirmed until <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent has the <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, the risk to the sibs of inheriting the pathogenic variant is 50%.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for susceptibility to IIAE3 because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with susceptibility to infection-induced acute encephalopathy 3 has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, his or her family members may be at risk.</p></div><div id="iiae3.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#iiae3.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives so that those who have inherited the <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can benefit from prompt intervention in the early stages of ANE.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant, the variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults at risk for IIAE3.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="iiae3.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for susceptibility to infection-induced acute encephalopathy 3 are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While decisions regarding prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="iiae3.Resources"><h2 id="_iiae3_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Encephalopathy-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Encephalopathy Information Page</a></div></li></ul></div><div id="iiae3.Molecular_Genetics"><h2 id="_iiae3_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="iiae3.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Susceptibility to Infection-Induced Acute Encephalopathy 3: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK258641/table/iiae3.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iiae3.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_iiae3.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_iiae3.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_iiae3.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_iiae3.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_iiae3.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_iiae3.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_iiae3.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5903" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RANBP2</i></a></td><td headers="hd_b_iiae3.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5903" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">2q13</a></td><td headers="hd_b_iiae3.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P49792" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">E3 SUMO-protein ligase RanBP2</a></td><td headers="hd_b_iiae3.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/RANBP2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RANBP2 database</a></td><td headers="hd_b_iiae3.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RANBP2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RANBP2</a></td><td headers="hd_b_iiae3.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RANBP2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RANBP2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="iiae3.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="iiae3.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Susceptibility to Infection-Induced Acute Encephalopathy 3 (<a href="/omim/601181,608033" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK258641/table/iiae3.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iiae3.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601181" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601181</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RAN-BINDING PROTEIN 2; RANBP2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608033" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608033</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>RANBP2</i> encodes for a 29-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> with a full-length spliced transcript of 11711 bp. <i>RANBP2</i> is known to be the original gene in a series of gene <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> events leading to a series of hybrid genes designated as <i>RGPD1</i> through <i>RGPD8</i> [<a class="bk_pop" href="#iiae3.REF.ciccarelli.2005.343">Ciccarelli et al 2005</a>]. Duplications and deletions arising from nonhomologous <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> occur throughout this region, but to date have not been associated with ANE. For a detailed summary of gene and protein information, see <a href="/books/NBK258641/#iiae3.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> In an event specific to primates, a series of rearrangement and <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> events has led to eight derivative genes termed "<i>RGPD</i>s" [<a class="bk_pop" href="#iiae3.REF.ciccarelli.2005.343">Ciccarelli et al 2005</a>] which encode for "RANBP2-like and GRIP <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> containing proteins." Most of the benign variants in <a href="/snp/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">dbSNP</a> reported in the <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> coding sequence of <i>RANBP2</i> are not true polymorphisms, but are stable base substitutions that are nonspecifically amplified from the <i>RGPD</i>s. Special primer conditions must be used when <a class="def" href="/books/n/gene/glossary/def-item/sanger-sequencing/">Sanger sequencing</a> the primary <i>RANBP2</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#iiae3.REF.neilson.2009.44">Neilson et al 2009</a>]. Caution must be used when interpreting normal and abnormal alleles, as they may represent nonspecific amplifications of the derivative paralogs.</p><p><b>Pathogenic variants.</b> See <a class="figpopup" href="/books/NBK258641/table/iiae3.T.ranbp2_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figiiae3Tranbp2pathogenicvariantsdiscu" rid-ob="figobiiae3Tranbp2pathogenicvariantsdiscu">Table 2</a>.</p><div id="iiae3.T.ranbp2_pathogenic_variants_discu" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>RANBP2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK258641/table/iiae3.T.ranbp2_pathogenic_variants_discu/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__iiae3.T.ranbp2_pathogenic_variants_discu_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1754C&#x0003e;T</td><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr585Met</td><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_006267.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006267<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_006258.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006258<wbr style="display:inline-block"></wbr>​.3</a></td></tr><tr><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1958C&#x0003e;T</td><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr653Ile</td></tr><tr><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1966A&#x0003e;G</td><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile656Val</td><td headers="hd_h_iiae3.T.ranbp2_pathogenic_variants_discu_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RANBP2</i> encodes a mature protein of 3224 amino acids. Its molecular weight is approximately 358 kd, for which the protein was previously named NUP358. RANBP2 has multiple functional domains and multiple roles within the cell. It contains a nuclear envelope localizing signal, four RAN binding domains, a series of zinc finger repeats, an E3 SUMO ligase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, and a cyclophilin A domain [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>].</p><p>RANBP2 contributes to the nuclear filaments present on the cytoplasmic surface of the nuclear pore. RANBP2 has been shown to participate in multiple functions including nuclear import and export, intracellular trafficking, mitochondrial distribution, and maintenance of chromosomal mitotic segregation. It also serves as a nuclear docking site for certain viruses, such as HIV [<a class="bk_pop" href="#iiae3.REF.neilson.2010.751">Neilson 2010</a>, <a class="bk_pop" href="#iiae3.REF.di_nunzio.2012.e46037">Di Nunzio et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> At present, it is unclear how the <i>RANBP2</i> protein causes the disease state.</p><div id="iiae3.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>Sporadic cancers (including myelomonoctyic leukemia and inflammatory myofibroblastic tumor) occurring as single tumors in the absence of any other findings of this syndrome may harbor somatic variants in <i>RANBP2</i> that are not present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a>; thus, predisposition to these tumors is not heritable. A <a class="def" href="/books/n/gene/glossary/def-item/recombination/">recombination</a> between <i>RANBP2</i> and <i>ALK</i> resulting in a chimeric fusion protein has been described most commonly [<a class="bk_pop" href="#iiae3.REF.patel.2007.107">Patel et al 2007</a>, <a class="bk_pop" href="#iiae3.REF.chen.2008.1854">Chen &#x00026; Lee 2008</a>, <a class="bk_pop" href="#iiae3.REF.li.2013.147">Li et al 2013</a>, <a class="bk_pop" href="#iiae3.REF.lim.2014.40">Lim et al 2014</a>]. The amino terminal portion of RANBP2 causes ALK to be localized and inappropriately active at the nuclear surface.</p></div></div><div id="iiae3.References"><h2 id="_iiae3_References_">References</h2><div id="iiae3.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.alper.2012.1408">Alper G. Acute disseminated encephalomyelitis. <span><span class="ref-journal">J Child Neurol. </span>2012;<span class="ref-vol">27</span>:1408–25.</span> [<a href="/pubmed/22914374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22914374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.ashtekar.2003.634">Ashtekar CS, Jaspan T, Thomas D, Weston V, Gayatri NA, Whitehouse WP. Acute bilateral thalamic necrosis in a child with Mycoplasma pneumoniae. <span><span class="ref-journal">Dev Med Child Neurol. </span>2003;<span class="ref-vol">45</span>:634–7.</span> [<a href="/pubmed/12948332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12948332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.aydin.2010.1281">Aydin H, Ozgul E, Agildere AM. Acute necrotizing encephalopathy secondary to diphtheria, tetanus toxoid and whole-cell pertussis vaccination: diffusion-weighted imaging and proton MR spectroscopy findings. <span><span class="ref-journal">Pediatr Radiol. </span>2010;<span class="ref-vol">40</span>:1281–4.</span> [<a href="/pubmed/20119724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20119724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.baertling.2014.257">Baertling F, Rodenburg RJ, Schaper J, Smeitink JA, Koopman WJ, Mayatepek E, Morava E, Distelmaier F. A guide to diagnosis and treatment of Leigh syndrome. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2014;<span class="ref-vol">85</span>:257–65.</span> [<a href="/pubmed/23772060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23772060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.bergamino.2012.384">Bergamino L, Capra V, Biancheri R, Rossi A, Tacchella A, Ambrosini L, Mizuguchi M, Saitoh M, Marazzi MG. Immunomodulatory therapy in recurrent acute necrotizing encephalopathy ANE1: is it useful? <span><span class="ref-journal">Brain Dev. </span>2012;<span class="ref-vol">34</span>:384–91.</span> [<a href="/pubmed/21945312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21945312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.chen.2008.1854">Chen ST, Lee JC. An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features. <span><span class="ref-journal">Hum Pathol. </span>2008;<span class="ref-vol">39</span>:1854–8.</span> [<a href="/pubmed/18701132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18701132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.ciccarelli.2005.343">Ciccarelli FD, Von Mering C, Suyama M, Harrington ED, Izaurralde E, Bork P. Complex genomic rearrangements lead to novel primate gene function. <span><span class="ref-journal">Genome Res. </span>2005;<span class="ref-vol">15</span>:343–51.</span> [<a href="/pmc/articles/PMC551560/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC551560</span></a>] [<a href="/pubmed/15710750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15710750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.di_nunzio.2012.e46037">Di Nunzio F, Danckaert A, Fricke T, Perez P, Fernandez J, Perret E, Roux P, Shorte S, Charneau P, Diaz-Griffero F, Arhel NJ. Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e46037.</span> [<a href="/pmc/articles/PMC3457934/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3457934</span></a>] [<a href="/pubmed/23049930" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23049930</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.goenka.2014.775">Goenka A, Michael BD, Ledger E, Hart IJ, Absoud M, Chow G, Lilleker J, Lunn M, Mckee D, Peake D, Pysden K, Roberts M, Carrol ED, Lim M, Avula S, Solomon T, Kneen R. Neurological manifestations of influenza infection in children and adults: Results of a National British Surveillance study. <span><span class="ref-journal">Clin Infect Dis. </span>2014;<span class="ref-vol">58</span>:775–84.</span> [<a href="/pubmed/24352349" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24352349</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.kansagra.2011.400">Kansagra SM, Gallentine WB. Cytokine storm of acute necrotizing encephalopathy. <span><span class="ref-journal">Pediatr Neurol. </span>2011;<span class="ref-vol">45</span>:400–2.</span> [<a href="/pubmed/22115004" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22115004</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.karussis.2014.134">Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review. <span><span class="ref-journal">J Autoimmun. </span>2014;<span class="ref-vol">48-49</span>:134–42.</span> [<a href="/pubmed/24524923" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24524923</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.larsen.1996.1124">Larsen PD, Crisp D. Acute bilateral striatal necrosis associated with Mycoplasma pneumoniae infection. <span><span class="ref-journal">Pediatr Infect Dis J. </span>1996;<span class="ref-vol">15</span>:1124–6.</span> [<a href="/pubmed/8970225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8970225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.li.2013.147">Li J, Yin WH, Takeuchi K, Guan H, Huang YH, Chan JK. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review. <span><span class="ref-journal">Diagn Pathol. </span>2013;<span class="ref-vol">8</span>:147.</span> [<a href="/pmc/articles/PMC3850018/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3850018</span></a>] [<a href="/pubmed/24034896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24034896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.lim.2014.40">Lim JH, Jang S, Park CJ, Cho YU, Lee JH, Lee KH, Lee JO, Shin JY, Kim JI, Huh J, Seo EJ. RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia. <span><span class="ref-journal">Cancer Genet. </span>2014;<span class="ref-vol">207</span>:40–5.</span> [<a href="/pubmed/24613277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24613277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.marco.2010.e693">Marco EJ, Anderson JE, Neilson DE, Strober JB. Acute necrotizing encephalopathy in 3 brothers. <span><span class="ref-journal">Pediatrics. </span>2010;<span class="ref-vol">125</span>:e693–8.</span> [<a href="/pmc/articles/PMC3207236/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3207236</span></a>] [<a href="/pubmed/20142283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20142283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.mizuguchi.1997.81">Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. <span><span class="ref-journal">Brain Dev. </span>1997;<span class="ref-vol">19</span>:81–92.</span> [<a href="/pubmed/9105653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9105653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.mizuguchi.1995.555">Mizuguchi M, Abe J, Mikkaichi K, Noma S, Yoshida K, Yamanaka T, Kamoshita S. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>1995;<span class="ref-vol">58</span>:555–61.</span> [<a href="/pmc/articles/PMC1073485/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1073485</span></a>] [<a href="/pubmed/7745402" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7745402</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.neilson.2010.751">Neilson DE. The interplay of infection and genetics in acute necrotizing encephalopathy. <span><span class="ref-journal">Curr Opin Pediatr. </span>2010;<span class="ref-vol">22</span>:751–7.</span> [<a href="/pubmed/21610332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21610332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.neilson.2009.44">Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, Kerr DS, Anderson J, Bassuk AG, Bye AM, Childs AM, Clarke A, Crow YJ, Di Rocco M, Dohna-Schwake C, Dueckers G, Fasano AE, Gika AD, Gionnis D, Gorman MP, Grattan-Smith PJ, Hackenberg A, Kuster A, Lentschig MG, Lopez-Laso E, Marco EJ, Mastroyianni S, Perrier J, Schmitt-Mechelke T, Servidei S, Skardoutsou A, Uldall P, Van Der Knaap MS, Goglin KC, Tefft DL, Aubin C, De Jager P, Hafler D, Warman ML. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">84</span>:44–51.</span> [<a href="/pmc/articles/PMC2668029/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2668029</span></a>] [<a href="/pubmed/19118815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19118815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.neilson.2003.226">Neilson DE, Eiben RM, Waniewski S, Hoppel CL, Varnes ME, Bangert BA, Wiznitzer M, Warman ML, Kerr DS. Autosomal dominant acute necrotizing encephalopathy. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">61</span>:226–30.</span> [<a href="/pubmed/12874403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12874403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.okumura.2009.221">Okumura A, Mizuguchi M, Kidokoro H, Tanaka M, Abe S, Hosoya M, Aiba H, Maegaki Y, Yamamoto H, Tanabe T, Noda E, Imataka G, Kurahashi H. Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. <span><span class="ref-journal">Brain Dev. </span>2009;<span class="ref-vol">31</span>:221–7.</span> [<a href="/pubmed/18456443" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18456443</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.patel.2007.107">Patel AS, Murphy KM, Hawkins AL, Cohen JS, Long PP, Perlman EJ, Griffin CA. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. <span><span class="ref-journal">Cancer Genet Cytogenet. </span>2007;<span class="ref-vol">176</span>:107–14.</span> [<a href="/pubmed/17656252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17656252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.shinohara.2011.512">Shinohara M, Saitoh M, Takanashi J, Yamanouchi H, Kubota M, Goto T, Kikuchi M, Shiihara T, Yamanaka G, Mizuguchi M. Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases. <span><span class="ref-journal">Brain Dev. </span>2011;<span class="ref-vol">33</span>:512–7.</span> [<a href="/pubmed/20934285" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20934285</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.shinya.2000.187">Shinya K, Shimada A, Ito T, Otsuki K, Morita T, Tanaka H, Takada A, Kida H, Umemura T. Avian influenza virus intranasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. <span><span class="ref-journal">Arch Virol. </span>2000;<span class="ref-vol">145</span>:187–95.</span> [<a href="/pubmed/10664417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10664417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="iiae3.REF.yoshida.2013.921">Yoshida T, Tamura T, Nagai Y, Ueda H, Awaya T, Shibata M, Kato T, Heike T. MRI gadolinium enhancement precedes neuroradiological findings in acute necrotizing encephalopathy. <span><span class="ref-journal">Brain Dev. </span>2013;<span class="ref-vol">35</span>:921–4.</span> [<a href="/pubmed/23265619" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23265619</span></a>]</div></li></ul></div></div><div id="iiae3.Chapter_Notes"><h2 id="_iiae3_Chapter_Notes_">Chapter Notes</h2><div id="iiae3.Acknowledgments"><h3>Acknowledgments</h3><p>Special thanks to the families who participated in this genetic research and to the physicians, genetic counselors, and nurses who helped facilitate that process.</p></div><div id="iiae3.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>4 December 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>19 February 2014 (dn) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK258641</span><span class="label">PMID: <a href="/pubmed/25473726" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">25473726</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ssadh/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cdsp/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK258641&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK258641/?report=reader">PubReader</a></li><li><a href="/books/NBK258641/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK258641" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK258641" style="display:none" title="Cite this Page"><div class="bk_tt">Neilson D. Susceptibility to Infection-Induced Acute Encephalopathy 3. 2014 Dec 4. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK258641/pdf/Bookshelf_NBK258641.pdf">PDF version of this page</a> (425K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#iiae3.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#iiae3.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#iiae3.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#iiae3.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#iiae3.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#iiae3.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#iiae3.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#iiae3.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#iiae3.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#iiae3.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#iiae3.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5903[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RANBP2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3313256" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3313256" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3313256" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3313256" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25128471" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Familial acute necrotizing encephalopathy due to mutation in the RANBP2 gene.</a><span class="source">[J Neurol Sci. 2014]</span><div class="brieflinkpop offscreen_noflow">Familial acute necrotizing encephalopathy due to mutation in the RANBP2 gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Denier C, Balu L, Husson B, Nasser G, Burglen L, Rodriguez D, Labauge P, Chevret L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Neurol Sci. 2014 Oct 15; 345(1-2):236-8. Epub 2014 Jul 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28336122" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Familial acute necrotizing encephalopathy with RANBP2 mutation: The first report in Northeast Asia.</a><span class="source">[Brain Dev. 2017]</span><div class="brieflinkpop offscreen_noflow">Familial acute necrotizing encephalopathy with RANBP2 mutation: The first report in Northeast Asia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lee YJ, Hwang SK, Lee SM, Kwon S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain Dev. 2017 Aug; 39(7):625-628. Epub 2017 Mar 21.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26923722" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Variable clinical course in acute necrotizing encephalopathy and identification of a novel RANBP2 mutation.</a><span class="source">[Brain Dev. 2016]</span><div class="brieflinkpop offscreen_noflow">Variable clinical course in acute necrotizing encephalopathy and identification of a novel RANBP2 mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sell K, Storch K, Hahn G, Lee-Kirsch MA, Ramantani G, Jackson S, Neilson D, von der Hagen M, Hehr U, Smitka M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain Dev. 2016 Sep; 38(8):777-80. Epub 2016 Feb 26.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23409300" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Variegate Porphyria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Variegate Porphyria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Singal AK, Anderson KE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20437615" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HTRA1</i> Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">HTRA1</i> Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Onodera O, Nozaki H, Fukutake T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=25473726" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=25473726" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b8a39a66ee2bacb3058">Susceptibility to Infection-Induced Acute Encephalopathy 3 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Susceptibility to Infection-Induced Acute Encephalopathy 3 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:39:54-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D6293E0414061000000000ACB0409&amp;ncbi_session=CE8D6293E042B891_2763SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK258641%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK258641&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK258641/&amp;ncbi_pagename=Susceptibility to Infection-Induced Acute Encephalopathy 3 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D6293E042B891_2763SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>